No. | Exclusion criteria |
---|---|
1 | ASA grade >3 |
2 | Pregnant or lactating women |
3 | Midline or transverse laparotomy within the last 60 days prior to trial intervention |
4 | Planned relaparotomy within 30 days after trial intervention |
5 | Contaminated operations according to CDC definition [9] |
6 | Small abdominal operations without planned transverse or midline laparotomy (for example, appendectomy) |
7 | Concurrent abdominal wall infections |
8 | Severe immunosuppression, for example after: organ or bone marrow transplantation, concurrent steroid treatment with >10 mg prednisone daily (or an equivalent dose of any other steroid), concurrent infliximab treatment or treatment with an equivalent immunosuppressive substance, or chemotherapy within the last 2 weeks prior to trial intervention |
9 | Severe preoperative neutropenia (≤0.5 × 109 cells/l) |
10 | Liver cirrhosis; Child-Pugh B or C [43] |